Notes:
1. Free cash flow defined as net cash flow from operating activities (excluding disposal related costs) after net interest paid, net purchases of non-current assets and investments and the principal elements of lease payments, adjusted to reflect the classification of Catalyst Technologies as a discontinued operation. 2024/25: £64 million inflow.
2. Pro forma financials exclude Catalyst Technologies (discontinued) and Value Businesses (divested) as shown on page 10 (of full release).
3. Enterprise value of £1,325 million on a cash and debt-free basis.
4. Comprising £800 million through a special dividend with a share consolidation, and £200 million through an on -market share buyback programme.
5. Acquisition of Cormetech for an enterprise value of $360 million payable in cash, which represents a 10.3x acquisition multiple pre-synergies based on expected 2026 EBITDA of c.$35 million. An additional earn-out consideration of up to $100 million in total may be payable in cash during calendar years 2028 and 2029, conditional on Cormetech achieving certain financial performance targets. Further detail included in the transaction announcement.